Skip to main content
SpringerLink
Log in

Endocarditis

  • Chapter
  • First Online:
Management of Antimicrobials in Infectious Diseases

Part of the book series: Infectious Disease ((ID))

  • 1710 Accesses

Abstract

Infective endocarditis (IE) is an important cause of morbidity and mortality, and the incidence of this disease among the elderly, recipients of prosthetic valves, and intravenous drug abusers has been increasing. The emergence of microbial resistance has complicated treatment of this disease. Primary prevention, early disease recognition, and prompt treatment are vital in reducing the incidence of IE as well as its complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Stamboulina D, Carbone E (1997). Recognition, management and prophylaxis of endocarditis. Drugs 54:730–744

    Article  Google Scholar 

  2. Pawsat DE, Lee JY (1998). Inflammatory disorders of the heart. Emerg Med Clin North Am 16:673–679

    Article  Google Scholar 

  3. Sandre RM, Shafran SD (1996). Infective endocarditis: Review of 135 cases over 9 years. Clin Infect Dis 22:276–286

    Article  PubMed  CAS  Google Scholar 

  4. Nandakumar R, Raju G (1997). Isolated tricuspid valve endocarditis in nonaddicted patients: A diagnostic challenge. Am J Med Sci 314:207–212

    Article  PubMed  CAS  Google Scholar 

  5. Gagliardi JP, Nettles RE, McCarty DE et al. (1998). Native valve infective endocarditis in elderly and younger adult patients: Comparison of clinical features and outcomes with use of the Duke criteria and the Duke endocarditis database. Clin Infect Dis 26:1165–1168

    Article  PubMed  CAS  Google Scholar 

  6. Cacoub P, Leprince P, Nataf P et al. (1998). Pacemaker infective endocarditis. Am J Cardiol 82:480–484

    Article  PubMed  CAS  Google Scholar 

  7. Kjerulf A, Tvede M, Aldershvile J et al. (1998). Bacterial endocarditis at a tertiary hospital- how do we improve diagnosis and delay of treatment? Cardiology 89:79–86

    Article  PubMed  CAS  Google Scholar 

  8. Hoesley CJ, Cobbs CG (1999). Endocarditis at the millennium. J Infect Dis 179:s360–s365

    Article  PubMed  Google Scholar 

  9. Bayer AS, Bolger AF, Taubert KA et al. (1998). Diagnosis and management of infective endocarditis and its complications. Circulation 98:2936–2948

    PubMed  CAS  Google Scholar 

  10. Bayer AS (1993). Infective endocarditis. Clin Ifect Dis 17:313–320

    Article  CAS  Google Scholar 

  11. Hoen B, Selton-Suty C, Lacassin F et al. (1993). Infective endocarditis in patients with negative blood cultures: Analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 17:313–320

    Article  Google Scholar 

  12. Lamas CC, Eykyn SJ (1998). Hospital acquired native valve endocarditis: Analysis of 22 cases presenting over 11 years. Hear 79:442–447

    CAS  Google Scholar 

  13. Selton-Suty C, Hoen B, Grentzinger A et al. (1997). Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart 77:260–263

    Article  PubMed  CAS  Google Scholar 

  14. Pasic M, Hetzer R (1998). Myocardial complications of acute mitral valve endocarditis. Circulation 98:489

    PubMed  CAS  Google Scholar 

  15. Siddiq S, Missri J, Silverman DI (1996). Endocarditis in an urban hospital in the 1990s. Arch Intern Med 156:2425–2458

    Article  Google Scholar 

  16. Brown M, Griffin GE (1998). Immune responses in endocarditis. Heart 79:1–2

    PubMed  CAS  Google Scholar 

  17. Agarwal A, Clements J, Sedmak D et al. (1997). Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol 8:1971–1976

    PubMed  CAS  Google Scholar 

  18. Lamas CC, Eykyn SJ (1997). Suggested modifications to the Duke criteria for the clinical diagnosis of native valve prosthetic valve endocarditis: Analysis of 118 pathologically proven cases. Clin Infect Dis 25:713–719

    Article  PubMed  CAS  Google Scholar 

  19. Durak DT, Lukes AS, Bright DK (1994). New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings: Duke Endocarditis Service. Am J Med 96:200–209

    Article  Google Scholar 

  20. Lancellotti P, Galiuto L, Albert A et al. (1996). Relative value of clinical and transesophageal echocardiographic variables for risk stratification in patients with infective endocarditis. Cardiol Clin 14:351–362

    Article  Google Scholar 

  21. Saccente M, Cobbs CG (1996). Clinical approach to infective endocarditis. Cardiol Clin 14:351–362

    Article  PubMed  CAS  Google Scholar 

  22. Litler WA (1998). Antimicrobial therapy for bacterial endocarditis on native valves. J Infect Dis 36:137–139

    Google Scholar 

  23. Nissen H, Neilsen PF, Frederiksen M et al. (1992). Native valve infective endocarditis in the general population: A 10-year survey of the clinical picture during the 1980’s. Eur Heart J 13:872–877

    PubMed  CAS  Google Scholar 

  24. Shively BK, Gurule FT, Roldan CA et al. (1991). Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 18:391–397

    Article  PubMed  CAS  Google Scholar 

  25. Baddour LM, Wilson WR, Bayer AS et al. (2005). Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association – Executive summary: Endorsed by the Infectious Diseases Society of America. Circulation 111:3167–3184

    Article  Google Scholar 

  26. Tacconelli E, Tumbarello M, de Gaetano K et al. (1998). Native valve endocarditis due to a nocardia-like organism. Clin Infect Dis 27:902

    Article  Google Scholar 

  27. Vongpatanasin W, Hillis LD, et al. (1996). Prosthetic Heart Valves. N Engl J Med 335:407–416

    Article  PubMed  CAS  Google Scholar 

  28. John MDV, Hibberd PL, Karchmer AW et al. (1998). Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death. Clin Infect Dis 26:1302–1309

    Article  PubMed  CAS  Google Scholar 

  29. Kupferwasser J, Darius H, Muller AM et al. (1998). Clinical and morphological characteristics in Streptoccus bovis endocarditis: A comparison with other causative microorganisms in 177 cases. Heart 80:276–280

    PubMed  CAS  Google Scholar 

  30. Klein RS, Catalano MT, Edberg SC et al. (1979). Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 91:560

    PubMed  CAS  Google Scholar 

  31. Chang FY, Peacock JE, Jr., Musher DM et al. (2003). Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 82:333–339

    Article  PubMed  CAS  Google Scholar 

  32. Anguera I, Del Rio A, Miro JM, Matinez-Lacasa X (2005). Staphylococcus lugdunensis infective endocarditis: Description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart 91:e10

    Article  PubMed  CAS  Google Scholar 

  33. Lessing MP, Crook DW, Bowler IC et al. (1996). Native valve endocarditis caused by Staphylococcus lugdunensis endocarditis. Q J Med 89:855–858

    CAS  Google Scholar 

  34. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Streptococcus pneumoniae, 2006-provisional.

    Google Scholar 

  35. Aronin SI, Mukherjee SK, West JC et al. (1998). Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis 26:165–171

    Article  PubMed  CAS  Google Scholar 

  36. Chang FY, MacDonald BB, Peacock JE, Jr. (2003). A prospective multicenter study of Staphylococcus aureus Bacteremia: Incidence of endocarditis, Risk factors for mortality, and clinical impact of methicillin resistance. Medicine 82(5):322–332

    Article  PubMed  Google Scholar 

  37. Kim YS, Liu Q, Chow LL et al. (1998). Comparative efficacy of trovafloxacin in experimental enocarditis caused by ciprogloxacin-sensitive, methicillin-resistant Staphylococcus Aureus. Antimicro Agents Chemother 42:3325–3327

    CAS  Google Scholar 

  38. Mallory MA, Nettles RE, Alspaugh A et al. (1998). Community-acquired prosthetic valve endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 42:3325–3327

    Google Scholar 

  39. Murray BE (1997). Vancomycin-resistant enterococci. Am J Med 101:284–293

    Article  Google Scholar 

  40. Bonow RO, Carabello BA, Chatterjee K et al. (2006). ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1988 guidelines for the management of patients with valvular heart disease). Circulation 114:e156–e166

    Article  Google Scholar 

  41. Fowler VG, Jr, Miro JM, Hoen B et al. (2002). Staphylococcus aureus endocarditis: A consequence of medical progress. JAMA 288:75

    Article  Google Scholar 

  42. Drees M, Boucher H (2006). New agents for Staphylococcus aureus endocarditis. Curr Opin Infect Dis 19:544–550

    Article  PubMed  CAS  Google Scholar 

  43. Dailey CF, Leto-Fang CL, Buchana LV et al. (2001). Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45:2304–2308

    Article  PubMed  CAS  Google Scholar 

  44. Fowler VG, Jr, Boucher HW, Corey GR et al. (2006). Daptomycin versus standard therapy for Staphylococcus aureus bacteremia and endocarditis. N Engl J Med 355:653–665

    Article  PubMed  CAS  Google Scholar 

  45. Murphy TM, Deitz JM, Petersen PJ et al. (2000). Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis. Antimicrob Agents Chemother 44:3022–3027

    Article  PubMed  CAS  Google Scholar 

  46. Landman D, Quale JM (1997). Management of infections due to resistant enterococci: A review of therapeutic options. J Antimicrob Chemother 40:161–170

    Article  PubMed  CAS  Google Scholar 

  47. Pendergast BD (2006). The changing face of infective endocarditis. Heart 92:879–885

    Article  Google Scholar 

  48. Stevens MP, Edmond MB (2005). Endocarditis due to vancomycin-resistant enterococci: Case report and review of the literature. Clin Infect Dis 43:1134

    Article  Google Scholar 

  49. Yamaguchi H, Kiyoyuki E (2007). Surgical treatment of active infective mitral valve endocarditis. Ann Thorac Cardiovasc Surg 13:150–155

    PubMed  Google Scholar 

  50. Beyon RP, Bahl VK, Prendergast BD (2006). Infective endocarditis. Bri Med J 333:334–336

    Article  Google Scholar 

  51. Zirakzadeh A, Patel R (2006). Vancomycin resistant enterococci: Colonization, infection, detection and treatment. Mayo Clin Proc 81(4):529–536

    Article  PubMed  CAS  Google Scholar 

  52. Moon MR, Stinson EB, Miller DC (1997). Surgical treatment of endocarditis. Prog Cardivasc Dis 40:239–264

    Article  CAS  Google Scholar 

  53. Bauernschmitt R, Jakob HG, Vahl CF et al. (1998). Operation for infective endocarditis: Results after implantation of mechanical valves. Ann Thorac Surg 26:13100–13111

    Google Scholar 

  54. Fowler VG, Sexton DJ (1997). Editorial response: The role of valve replacement in the treatment of prosthetic valve endocarditis. Clin Infect Dis 25:1448–1458

    Article  Google Scholar 

  55. Habib G (2006). Management of infective endocarditis. Heart 92:124–130

    Article  PubMed  Google Scholar 

  56. Dajani AS, Taubert KA, Wilson W (1997). Prevention of bacterial endocarditis: Recommendations by the American Heart Association. Clin Infec Dis 25:1448–1558

    Article  CAS  Google Scholar 

  57. Wilson W, Taubert KA, Gewitz M (2007). Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116(15):1736–1754. 2007 Oct 9 Epub 2007 Apr 19. Erratum in: Circulation. 116(15):e376–377

    Article  PubMed  Google Scholar 

  58. Hogevik H, Alestig K (1996). Fungal endocarditis – A report on seven cases and a brief review. Infection 1:17–19

    Article  Google Scholar 

  59. Ellis M (1997). Fungal endocarditis. J Infect 35:99–103

    Article  PubMed  CAS  Google Scholar 

  60. Gilbert HM, Peters ED, Lang SJ et al. (1996). Successful treatment of fungal prosthetic valve endocarditis: Case report and review. Clinical Infect Dis 22:348–354

    Article  CAS  Google Scholar 

  61. Melgar GR, Nasser RM, Gordon SM et al. (1997). Fungal prosthetic valve endocarditis in 16 patients. Medicin 76:94–103

    Article  CAS  Google Scholar 

  62. Pierrotti L, Baddor L (2002). Fungal endocarditis, 1995–2000. Chest 122:302–310

    Article  PubMed  Google Scholar 

  63. Joly V, Carbon C (1998). Editorial response: Unfortunate in-vitro selection of resistant Candida albicans with severe clinical consequences. Clin Infect Dis 27:692–694

    Article  PubMed  CAS  Google Scholar 

  64. Ellis ME, Al-abdely H, Sandridge A et al. (2001). Fungal endocarditis: Evidence in the world of literature, 1965–1995. Clin Infect Dis 32:50–62

    Article  PubMed  CAS  Google Scholar 

  65. Petrikkos G, Skiada A (2007). Recent advances in antifungal chemotherapy. Int J Antimicrob Agents 30:108–117

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, Medical University of South Carolina, Charleston, SC, USA

    Eric Matheson

Authors
  1. Eric Matheson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Matheson .

Editor information

Editors and Affiliations

  1. Dept. Family Medicine, Medical University of South Carolina, Calhoun St. 295, Charleston, 29425, U.S.A.

    Arch G. Mainous III

  2. School of Medicine, University of California, Davis, Davis, 95616, U.S.A.

    Claire Pomeroy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Matheson, E. (2010). Endocarditis. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-239-1_13

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-238-4

  • Online ISBN: 978-1-60327-239-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation